Consolidated Balance Sheets - USD ($) $ in Thousands	Dec. 30, 2017	Mar. 31, 2017
Assets
Cash and cash equivalents	$ 18,380	$ 14,247
Accounts receivable, net of allowance for doubtful accounts of $4,087 and $4,084	124,024	128,544
Inventories, net	30,896	25,382
Costs/estimated earnings in excess of billings on uncompleted contracts	86,945	71,930
Assets held for sale	297	0
Other assets	32,386	28,544
Total current assets	292,928	268,647
Property, plant and equipment, net	25,628	29,103
Intangibles, net	61,483	68,820
Deferred tax asset	34,771	53,539
Other assets	8,259	7,008
Total assets	423,069	427,117
Liabilities
Accounts payable	74,312	69,858
Accrued compensation and benefits	14,026	21,576
Deferred revenue	27,297	31,624
Billings in excess of costs/estimated earnings on uncompleted contracts	15,520	16,536
Short-term debt	6,754	964
Other liabilities	32,750	36,955
Total current liabilities	170,659	177,513
Long-term debt	136,031	88,782
Other liabilities	16,489	19,173
Total liabilities	323,179	285,468
Stockholders’ equity
Preferred stock authorized 5,000, par value $1.00, none issued	0	0
Common stock authorized 100,000, par value $.001, 15,139 and 14,960 shares outstanding, 26,878 and 26,654 issued	26	26
Additional paid-in capital	509,830	506,449
Retained earnings	15,346	66,246
Accumulated other comprehensive income (loss)	(9,326)	(15,481)
Treasury stock, at cost 11,739 and 11,694 shares	(415,986)	(415,591)
Total stockholders’ equity	99,890	141,649
Total liabilities and stockholders’ equity	$ 423,069	$ 427,117